Annual report
4885.TEDINET S100RQQ8
Period2022-06-01 → 2023-05-31
Filed2023-08-25
StandardJapan GAAP
ConsolidatedNo
Data checks13 of 13 passed
Key figures · 102
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥6.3bn | 2022-06-01 → 2023-05-31 | Standalone | Net sales |
| Revenue | ¥5.7bn | 2021-06-01 → 2022-05-31 | Standalone | Net sales |
| Revenue | ¥4.9bn | 2020-06-01 → 2021-05-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥5.3bn | 2019-06-01 → 2020-05-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥5.4bn | 2018-06-01 → 2019-05-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥5.4bn | 2018-06-01 → 2019-05-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥369m | 2022-06-01 → 2023-05-31 | Standalone | Operating income |
| Operating income | ¥437m | 2021-06-01 → 2022-05-31 | Standalone | Operating income |
| Ordinary income | ¥351m | 2022-06-01 → 2023-05-31 | Standalone | Ordinary income |
| Ordinary income | ¥423m | 2021-06-01 → 2022-05-31 | Standalone | Ordinary income |
| Ordinary income | ¥339m | 2020-06-01 → 2021-05-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥272m | 2019-06-01 → 2020-05-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥278m | 2019-06-01 → 2020-05-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥91m | 2018-06-01 → 2019-05-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥108m | 2018-06-01 → 2019-05-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥351m | 2022-06-01 → 2023-05-31 | Standalone | Income before income taxes |
| Profit before tax | ¥426m | 2021-06-01 → 2022-05-31 | Standalone | Income before income taxes |
| Net income (owners) | ¥32m | 2019-06-01 → 2020-05-31d | Standalone | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥29m | 2018-06-01 → 2019-05-31d | Standalone | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥256m | 2022-06-01 → 2023-05-31 | Standalone | Profit loss |
| Net income | ¥456m | 2021-06-01 → 2022-05-31 | Standalone | Profit loss |
| Net income | ¥181m | 2020-06-01 → 2021-05-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥34m | 2019-06-01 → 2020-05-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥112m | 2018-06-01 → 2019-05-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥4.9bn | at 2023-05-31 | Standalone | Assets |
| Total assets | ¥4.8bn | at 2022-05-31 | Standalone | Assets |
| Total assets | ¥4.6bn | at 2021-05-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥4.8bn | at 2020-05-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥4.6bn | at 2019-05-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥4.6bn | at 2019-05-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥3.0bn | at 2023-05-31 | Standalone | Liabilities |
| Total liabilities | ¥3.1bn | at 2022-05-31 | Standalone | Liabilities |
| Net assets / equity | ¥1.9bn | at 2023-05-31 | Standalone | Net assets |
| Net assets / equity | ¥1.7bn | at 2022-05-31 | Standalone | Net assets |
| Net assets / equity | ¥1.3bn | at 2021-05-31d | Standalone | Net assets |
| Net assets / equity | ¥252m | at 2020-05-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥182m | at 2019-05-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥179m | at 2019-05-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥853m | at 2023-05-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥865m | at 2022-05-31 | Standalone | Cash and deposits |
| Cash & equivalents | ¥853m | at 2023-05-31 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥865m | at 2022-05-31 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥1.0bn | at 2021-05-31d | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥881m | at 2020-05-31d | Standalone | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥614m | at 2019-05-31d | Standalone | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥317m | 2022-06-01 → 2023-05-31 | Standalone | Net cash provided by used in operating activities |
| Operating cash flow | ¥525m | 2021-06-01 → 2022-05-31 | Standalone | Net cash provided by used in operating activities |
| Operating cash flow | ¥488m | 2020-06-01 → 2021-05-31d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥89m | 2019-06-01 → 2020-05-31d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥342m | 2018-06-01 → 2019-05-31d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥162m | 2022-06-01 → 2023-05-31 | Standalone | Net cash provided by used in investment activities |
| Investing cash flow | −¥176m | 2021-06-01 → 2022-05-31 | Standalone | Net cash provided by used in investment activities |
| Investing cash flow | −¥58m | 2020-06-01 → 2021-05-31d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | ¥137m | 2019-06-01 → 2020-05-31d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥311m | 2018-06-01 → 2019-05-31d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥172m | 2022-06-01 → 2023-05-31 | Standalone | Net cash provided by used in financing activities |
| Financing cash flow | −¥484m | 2021-06-01 → 2022-05-31 | Standalone | Net cash provided by used in financing activities |
| Financing cash flow | −¥311m | 2020-06-01 → 2021-05-31d | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥42m | 2019-06-01 → 2020-05-31d | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥23m | 2018-06-01 → 2019-05-31d | Standalone | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥67.94 | 2022-06-01 → 2023-05-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥123.79 | 2021-06-01 → 2022-05-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥65.24 | 2020-06-01 → 2021-05-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥15.75 | 2019-06-01 → 2020-05-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥17.16 | 2019-06-01 → 2020-05-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥14.46 | 2018-06-01 → 2019-05-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥55.99 | 2018-06-01 → 2019-05-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥64.12 | 2022-06-01 → 2023-05-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥112.56 | 2021-06-01 → 2022-05-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥56.97 | 2020-06-01 → 2021-05-31d | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥19 | 2022-06-01 → 2023-05-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥19 | 2021-06-01 → 2022-05-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥15 | 2020-06-01 → 2021-05-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥3 | 2019-06-01 → 2020-05-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥3 | 2018-06-01 → 2019-05-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥487.25 | at 2023-05-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥450.37 | at 2022-05-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥363.93 | at 2021-05-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥101.92 | at 2020-05-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥91.2 | at 2019-05-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥89.32 | at 2019-05-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 38.7% | at 2023-05-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 35.0% | at 2022-05-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 28.9% | at 2021-05-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 5.3% | at 2020-05-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 3.9% | at 2019-05-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 14.3% | 2022-06-01 → 2023-05-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 30.3% | 2021-06-01 → 2022-05-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 22.8% | 2020-06-01 → 2021-05-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 16.0% | 2019-06-01 → 2020-05-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 16.9% | 2018-06-01 → 2019-05-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 89.6% | 2018-06-01 → 2019-05-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 4,095,500 | at 2023-05-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 4,095,500 | at 2022-05-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 4,095,500 | at 2021-05-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 775,000 | at 2020-05-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,010,000 | at 2019-05-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 205 | at 2023-05-31 | Standalone | Number of employees |
| Employees | 197 | at 2022-05-31 | Standalone | Number of employees |
| Employees | 195 | at 2021-05-31d | Standalone | Number of employees |
| Employees | 196 | at 2020-05-31d | Standalone | Number of employees |
| Employees | 199 | at 2019-05-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 53
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | segment assets | at 2023-05-31 | ¥1.3bn |
| Chemical Products Businessreportable segment | capex | 2022-06-01 → 2023-05-31 | ¥37m |
| Chemical Products Businessreportable segment | depreciation | 2022-06-01 → 2023-05-31 | ¥50m |
| Chemical Products Businessreportable segment | employees | at 2023-05-31 | 54 pure |
| Chemical Products Businessreportable segment | revenue | 2022-06-01 → 2023-05-31 | ¥2.1bn |
| Chemical Products Businessreportable segment | revenue external | 2022-06-01 → 2023-05-31 | ¥2.1bn |
| Chemical Products Businessreportable segment | segment assets | at 2023-05-31 | ¥1.2bn |
| Chemical Products Businessreportable segment | segment profit | 2022-06-01 → 2023-05-31 | −¥50m |
| Healthy Food Businessreportable segment | capex | 2022-06-01 → 2023-05-31 | ¥17m |
| Healthy Food Businessreportable segment | depreciation | 2022-06-01 → 2023-05-31 | ¥28m |
| Healthy Food Businessreportable segment | employees | at 2023-05-31 | 28 pure |
| Healthy Food Businessreportable segment | revenue | 2022-06-01 → 2023-05-31 | ¥658m |
| Healthy Food Businessreportable segment | revenue external | 2022-06-01 → 2023-05-31 | ¥658m |
| Healthy Food Businessreportable segment | segment assets | at 2023-05-31 | ¥395m |
| Healthy Food Businessreportable segment | segment profit | 2022-06-01 → 2023-05-31 | −¥120m |
| Pharmaceutical Businessreportable segment | capex | 2022-06-01 → 2023-05-31 | ¥128m |
| Pharmaceutical Businessreportable segment | depreciation | 2022-06-01 → 2023-05-31 | ¥45m |
| Pharmaceutical Businessreportable segment | employees | at 2023-05-31 | 55 pure |
| Pharmaceutical Businessreportable segment | revenue | 2022-06-01 → 2023-05-31 | ¥3.5bn |
| Pharmaceutical Businessreportable segment | revenue external | 2022-06-01 → 2023-05-31 | ¥3.5bn |
| Pharmaceutical Businessreportable segment | segment assets | at 2023-05-31 | ¥2.0bn |
| Pharmaceutical Businessreportable segment | segment profit | 2022-06-01 → 2023-05-31 | ¥539m |
| Total Of Reportable Segments And Otherssegment total | capex | 2022-06-01 → 2023-05-31 | ¥181m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2022-06-01 → 2023-05-31 | ¥122m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-06-01 → 2023-05-31 | ¥6.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-06-01 → 2023-05-31 | ¥6.3bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2023-05-31 | ¥3.6bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-06-01 → 2023-05-31 | ¥369m |
| Reconciling Itemsreconciling | segment assets | at 2022-05-31 | ¥1.3bn |
| Chemical Products Businessreportable segment | capex | 2021-06-01 → 2022-05-31 | ¥39m |
| Chemical Products Businessreportable segment | depreciation | 2021-06-01 → 2022-05-31 | ¥55m |
| Chemical Products Businessreportable segment | revenue | 2021-06-01 → 2022-05-31 | ¥1.9bn |
| Chemical Products Businessreportable segment | revenue external | 2021-06-01 → 2022-05-31 | ¥1.9bn |
| Chemical Products Businessreportable segment | segment assets | at 2022-05-31 | ¥1.2bn |
| Chemical Products Businessreportable segment | segment profit | 2021-06-01 → 2022-05-31 | −¥16m |
| Healthy Food Businessreportable segment | capex | 2021-06-01 → 2022-05-31 | ¥116m |
| Healthy Food Businessreportable segment | depreciation | 2021-06-01 → 2022-05-31 | ¥11m |
| Healthy Food Businessreportable segment | revenue | 2021-06-01 → 2022-05-31 | ¥824m |
| Healthy Food Businessreportable segment | revenue external | 2021-06-01 → 2022-05-31 | ¥824m |
| Healthy Food Businessreportable segment | segment assets | at 2022-05-31 | ¥399m |
| Healthy Food Businessreportable segment | segment profit | 2021-06-01 → 2022-05-31 | ¥1m |
| Pharmaceutical Businessreportable segment | capex | 2021-06-01 → 2022-05-31 | ¥58m |
| Pharmaceutical Businessreportable segment | depreciation | 2021-06-01 → 2022-05-31 | ¥36m |
| Pharmaceutical Businessreportable segment | revenue | 2021-06-01 → 2022-05-31 | ¥2.9bn |
| Pharmaceutical Businessreportable segment | revenue external | 2021-06-01 → 2022-05-31 | ¥2.9bn |
| Pharmaceutical Businessreportable segment | segment assets | at 2022-05-31 | ¥2.0bn |
| Pharmaceutical Businessreportable segment | segment profit | 2021-06-01 → 2022-05-31 | ¥452m |
| Total Of Reportable Segments And Otherssegment total | capex | 2021-06-01 → 2022-05-31 | ¥213m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2021-06-01 → 2022-05-31 | ¥101m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-06-01 → 2022-05-31 | ¥5.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-06-01 → 2022-05-31 | ¥5.7bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2022-05-31 | ¥3.5bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-06-01 → 2022-05-31 | ¥437m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,211
| Item | Context | Value | Unit |
|---|---|---|---|
| Independent auditors report non consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 non consolidated | FilingDateInstant | Original text (Japanese)有限責任監査法人ト ー マ ツ | |
| Cpa1 audit firm1 non consolidated | FilingDateInstant | Original text (Japanese)増 村 正 之 | |
| Cpa2 audit firm1 non consolidated | FilingDateInstant | Original text (Japanese)宮 嵜 健 | |
| Key audit matters non consolidated (text) | FilingDateInstant | Text · Plus | |
| Overview kam non consolidated (text) | FilingDateInstant | Text · Plus | |
| Short description kam non consolidated | FilingDateInstant_Row1Member | Original text (Japanese)繰延税金資産の回収可能性 | |
| Description including reason kam non consolidated (text) | FilingDateInstant_Row1Member | Text · Plus | |
| Reference kam non consolidated | FilingDateInstant_Row1Member | Original text (Japanese)注記事項（税効果会計関係） | |
| Auditors response kam non consolidated (text) | FilingDateInstant_Row1Member | Text · Plus | |
| Other information non consolidated (text) | FilingDateInstant | Text · Plus | |
| Number of submission | FilingDateInstant | 1 | |
| Net sales (5-year summary) | Prior4YearDuration | 5420018000 | JPY |
| Net sales (5-year summary) | Prior3YearDuration | 5280306000 | JPY |
| Net sales (5-year summary) | Prior2YearDuration | － | JPY |
| Net sales (5-year summary) | Prior1YearDuration | － | JPY |
| Net sales (5-year summary) | CurrentYearDuration | － | JPY |
| Ordinary income loss (5-year summary) | Prior4YearDuration | 90996000 | JPY |
| Ordinary income loss (5-year summary) | Prior3YearDuration | 271851000 | JPY |
| Ordinary income loss (5-year summary) | Prior2YearDuration | － | JPY |
| Ordinary income loss (5-year summary) | Prior1YearDuration | － | JPY |
| Ordinary income loss (5-year summary) | CurrentYearDuration | － | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior4YearDuration | 28913000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior3YearDuration | 31570000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior2YearDuration | － | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YearDuration | － | JPY |
| Profit loss attributable to owners of parent (5-year summary) | CurrentYearDuration | － | JPY |
| Comprehensive income (5-year summary) | Prior4YearDuration | 24659000 | JPY |
| Comprehensive income (5-year summary) | Prior3YearDuration | 21397000 | JPY |
| Comprehensive income (5-year summary) | Prior2YearDuration | － | JPY |
| Comprehensive income (5-year summary) | Prior1YearDuration | － | JPY |
| Comprehensive income (5-year summary) | CurrentYearDuration | － | JPY |
| Net assets (5-year summary) | Prior4YearInstant | 182392000 | JPY |
| Net assets (5-year summary) | Prior3YearInstant | － | JPY |
| Net assets (5-year summary) | Prior2YearInstant | － | JPY |
| Net assets (5-year summary) | Prior1YearInstant | － | JPY |
| Net assets (5-year summary) | CurrentYearInstant | － | JPY |
| Total assets (5-year summary) | Prior4YearInstant | 4619342000 | JPY |
| Total assets (5-year summary) | Prior3YearInstant | － | JPY |
| Total assets (5-year summary) | Prior2YearInstant | － | JPY |
| Total assets (5-year summary) | Prior1YearInstant | － | JPY |
| Total assets (5-year summary) | CurrentYearInstant | － | JPY |
| Net assets per share (5-year summary) | Prior4YearInstant | 91.20 | |
| Net assets per share (5-year summary) | Prior3YearInstant | － | |
| Net assets per share (5-year summary) | Prior2YearInstant | － | |
| Net assets per share (5-year summary) | Prior1YearInstant | － | |
| Net assets per share (5-year summary) | CurrentYearInstant | － | |
| Basic earnings loss per share (5-year summary) | Prior4YearDuration | 14.46 | |
| Basic earnings loss per share (5-year summary) | Prior3YearDuration | 15.75 | |
| Basic earnings loss per share (5-year summary) | Prior2YearDuration | － |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 13 of 13 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |